Triple-agonist peptide studied for metabolic regulation and energy balance.
$2,099.00 MXN
Canada
3rd Party Tested
Lyophilized
Female metabolic regulation is influenced by hormonal cycles, insulin sensitivity shifts, and differences in fat distribution and energy utilization. Estrogen and progesterone impact glucose handling, appetite signaling, and mitochondrial efficiency in ways that differ from male physiology.
Research into multi-receptor peptides like Retatrutide is increasingly relevant in this context — examining how combined GLP-1, GIP, and glucagon pathway activation interacts with female-specific metabolic patterns.
These variables are critical when studying body composition, energy balance, and metabolic response beyond generalized models.
Targets GLP-1, GIP, and glucagon pathways simultaneously.
Studied for effects on appetite and caloric utilization.
Explored for impact on glucose and lipid metabolism.
Retatrutide has been investigated in recent studies as part of a new class of multi-agonist peptides designed to address complex metabolic systems. Research has examined its effects on weight regulation, insulin sensitivity, and energy expenditure.
Findings suggest that simultaneous activation of GLP-1, GIP, and glucagon receptors may produce synergistic effects across metabolic pathways, including appetite control and fat metabolism.
While research is ongoing, this compound represents a significant shift toward multi-pathway metabolic investigation rather than single-receptor targeting.
FemmeBioLabs presents these compounds within the context of available research — with a focus on accuracy, not exaggeration.
This site contains research compounds intended for adults
19 and older. Please confirm your age to continue.